 sleeping giant. What's up? I'm Giggs Mr. V here. Welcome to another video, guys. So in today's video, I want us to talk about Ticket Symbol, I.N.O. Inovio, a pharmaceutical. So this is a company that we profiled here on the channel before when we talked about our COVID-19 vaccine companies in Inovio was actually one of them. But ever since then, this stock has really struggled to make some moves and has just sit back and taking a vaccine from companies like Pfizer, Moderna, Johnson & Johnson. And I mean, like the guys that are leading the space today, we know that Pfizer's vaccine is currently being administered to people across the country. Moderna vaccine is on its way. So you're going to have two companies with their vaccines out there. But what we notice, if you look at the price for Moderna and Pfizer, the stock price just totally collapsed. It hasn't made any move. If you would think that companies announced vaccines like this, the stock prices are supposed to jump or skyrocket. But we see the complete opposite. Moderna pulled back to under 120 at one point. Pfizer is currently trading about $34. So there's been this crazy movement not really going along with the vaccine that these companies are putting out. So I want us to take a look at Inovio because what they are doing, even though they're really slow to get to market, but the vaccine is to me has a lot of promise. They are working on what I call a DNA vaccine, which is a complete different approach from the Moderna and Pfizer vaccine. And I'm going to show you guys some other advantages that this vaccine has in the marketplace that the competition doesn't have. But before we get started, guys, if you're new to the channel, we talk about how to earn money, how to save money, how to invest and build wealth. So if that's something that interests you, go ahead and hit that subscribe. And any notification bell so you don't miss out on new content. So if we see here, again, for Inovio, here's the latest news that came out, the fact that their vaccine, phase one trier, really turned out to look really, really good. So again, this is, let me bring that up here. So this is the information that I actually got. And that's why I wanted to do this video. They've gone back and after their issues with the FDA, they've gone back and just redoing their trials. And now they're going back to phase one. And now they're looking ahead. This is the vaccine that we have. And so far they've ran some tests and the clinical trials for that phase one is looking really, really promising. And that to me, that's good. And if you listen to most doctors and you see the reason why they think this vaccine is by far the best in the marketplace, even though the vaccine is not complete. But the idea that is doing a DNA vaccine is something that differentiates guys from the other companies. It was a race to the finish. We thought that whoever comes out with the vaccine first, the prior stock is going to completely explode. That has proven to not be the case because Pfizer stock has not exploded. Again, Moderna stock has not exploded. Like we anticipated. But now I'm looking like, hey, it looks like whoever comes out with the vaccine, that's going to do the work. That's going to be efficient. It's going to take one vaccine. And that said, you don't have to do two doses like you do with the Pfizer vaccine. I think that's going to be a game changer and Inovio is really on track for doing that. One of the things they need to be aware of is that even though Inovio is slow to get their vaccine, I think it's because of the fact that they do DNA. So it's not very easy to just run their clinical trials compared to the other companies. Then here's another thing that I want you guys to really keep an eye on because based on the information that I'm getting and reading, it means like that vaccine has a lot of efficiencies that the other ones don't have. Transportation wise, it's easy to transport. Storage wise, it's easy to store. You don't have to put it in refrigerator to transport it across the country. So it doesn't have to be frozen like you can see here which is excellent. We're talking about if you're taking this vaccine to remote areas and you have to worry about keeping it frozen, that's not really going to cut it because the cost of distribution is going to be very, very expensive. Renting containers that are half refrigerators that will keep it frozen. So again, this vaccine to me has an upside. Again, the stock right now is relatively cheap. If we look at the current price of the stock, it's trading somewhere at about $10 and some change. But if we're getting early now and just hold it for the long run and give these guys enough time to build this stock, if this vaccine comes out, this stock would be over $100 stock. Again, that's my personal prediction. So I'm looking more or so from the technology standpoint what these guys are doing. They're not just building a vaccine like the other guys. They're building something that it's going to change in the future. Again, I was looking like just the details as to how the vaccine works. I'm not a doctor. Never been to med school. But I see the way the vaccine works from a DNA standpoint has tremendous amount of promise compared to the current vaccines in the marketplace. So do some research about these guys. Read a little bit about them. There's a ton of information on the website. You can actually learn more about what they're working on from a vaccine standpoint. They don't have the reputation of a Pfizer or a Moderna. But if these guys come out with the vaccine that you can go in and take one shot and you're good to go. And again, the fact that it targets like the DNA I think is to me, it's huge, a huge amount of upside there. So definitely do some research on these companies. The other thing I wanted to bring up to you guys here is the last one in here that they actually have this funding from the US Defense Department. So they're still getting funding in order to because they see a tremendous amount of potential in their vaccines. So that's why these guys are getting a lot of funding from the government to keep their work going. So that's what I wanted to cover in this particular work for you guys. So I still think that if you are under $11 right now you can pick up a few shares of Inovio and just hold on to it. Again, my whole concept here is that for stocks that I think they're highly on the value, you pick somewhere between 50 and 100 shares and just hang on to it. This one is going to be a little bit of a weight for us because it's really dependent on this vaccine. And so just hang on to that. And then as we see more and more data comes out for the test when the phase two comes out, phase three. So looking to go for FDA approvers and then you can start adding and building that position. But then your dollar cost average is going to be really, really low because you started at $10. So that would be the game plan for this. So I still think that there's some good opportunity here. And I didn't want to just let you just want to sleep. This is to me, this is a sleeping giant and I don't want us to miss out on it. So again, let me know in the comment section what you think. If you're new to the channel guys, we talk about how to earn money, how to save money, how to invest and build wealth. So if that's something that interests you, go ahead and hit that subscribe button and the notification bell so you don't miss out on new content. And as always guys, always do your homework, don't be a greedy savage and stay motivated.